BUSINESSFINANCIAL TIMES WORLD
KKR nears over $4bn deal to buy medical device maker Integer Holdings
KKR is nearing a $4 billion deal to acquire medical device maker Integer Holdings. The healthcare company has been targeted by an activist hedge fund established by an alumnus of Elliott Management.
Mentioned
Related Signal
Adjacent reporting
- GSK to buy US cancer treatment firm Nuvalent for $10.6bn
- KKR is launching a $10 billion AI infrastructure company with Nvidia and Kuwait's sovereign fund
- GSK to buy US cancer treatment firm Nuvalent for $10.6bn
- GSK in talks to buy cancer biotech Nuvalent for more than $9bn
- STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
- GSK in Talks to Buy Nuvalent for More Than $9 Billion: FT